Board Certified Ambulatory Care Pharmacist (BCACP) Exam — Questions and Answers

Question 1: A patient taking simvastatin 80 mg is newly prescribed clarithromycin for a respiratory infection. What is the most appropriate pharmacist intervention?

Reduce simvastatin to 40 mg for the antibiotic duration
Counsel patient to watch for muscle pain but continue both drugs
Hold simvastatin during the 5-day antibiotic course (Correct answer)
Switch clarithromycin to azithromycin to avoid the interaction

Correct answer: Hold simvastatin during the 5-day antibiotic course

Clarithromycin is a potent CYP3A4 inhibitor that dramatically increases simvastatin exposure; holding the statin for the short antibiotic course is the recommended strategy.

Question 2: A 55-year-old woman with postmenopausal osteoporosis and a history of deep vein thrombosis asks about raloxifene. What is the most important contraindication to address?

Raloxifene is contraindicated in postmenopausal women
Raloxifene is contraindicated in patients with active or past VTE (Correct answer)
Raloxifene cannot be used without concurrent bisphosphonate therapy
Raloxifene is contraindicated in patients over age 50

Correct answer: Raloxifene is contraindicated in patients with active or past VTE

Raloxifene, a SERM, increases the risk of VTE and is contraindicated in patients with a history of venous thromboembolism.

Question 3: A patient with atrial fibrillation and a CrCl of 28 mL/min needs anticoagulation. Which DOAC requires the most significant dose adjustment in this scenario?

Edoxaban
Dabigatran (Correct answer)
Rivaroxaban
Apixaban

Correct answer: Dabigatran

Dabigatran is 80% renally eliminated and is contraindicated or requires the most cautious use in severe renal impairment (CrCl <30 mL/min for AF indication).

Question 4: A pharmacist wants to address medication adherence gaps across an entire patient panel. The MOST scalable first step is to:

Call each non-adherent patient individually
Review all discharge summaries from the past year
Wait for patients to report missed doses at clinic visits
Analyze pharmacy dispensing data to identify patients with PDC <0.80 (Correct answer)

Correct answer: Analyze pharmacy dispensing data to identify patients with PDC <0.80

Proportion of Days Covered (PDC) analysis of dispensing data allows efficient, data-driven identification of non-adherent patients across a large panel.

Question 5: A pharmacist is managing HIV PrEP in a patient who is unable to adhere to daily oral therapy. Which alternative is FDA-approved for HIV pre-exposure prophylaxis?

Cabotegravir extended-release injectable (Apretude) given every 2 months (Correct answer)
Maraviroc daily oral dosing
Rilpivirine monthly injection
Dolutegravir oral weekly dosing

Correct answer: Cabotegravir extended-release injectable (Apretude) given every 2 months

Cabotegravir long-acting injectable (Apretude) is FDA-approved for PrEP administered as an injection every 2 months after initial loading doses.

Question 6: A pharmacist is documenting a clinical encounter and uses CPT code 99497 for advance care planning. What does this code specifically describe?

Voluntary advance care planning discussion with or without completing advance directives, first 30 minutes face-to-face (Correct answer)
Transitional care management within 7 days of hospital discharge
Complex chronic care coordination, first 60 minutes per month
Annual wellness visit with medication reconciliation

Correct answer: Voluntary advance care planning discussion with or without completing advance directives, first 30 minutes face-to-face

CPT 99497 covers the first 30 minutes of voluntary face-to-face advance care planning discussion, which may include completing advance directive forms.

Question 7: Which antihypertensive is the preferred choice in a patient with hypertension and heart failure with reduced ejection fraction (HFrEF)?

Clonidine
Carvedilol (Correct answer)
Diltiazem
Amlodipine

Correct answer: Carvedilol

Carvedilol, a non-selective beta-blocker with alpha-1 blocking activity, is a guideline-directed medical therapy for HFrEF and also lowers blood pressure.

Question 8: A 50-year-old woman with obesity, hypertension, and osteoarthritis seeks advice on lifestyle changes for managing her hypertension. <br> <br> What is the MOST effective intervention for lowering blood pressure?

Increase caffeine intake for energy
Weight loss of 5-10% body weight (Correct answer)
Limit sodium intake to <2400 mg/day (Correct answer)
DASH diet (Correct answer)
Start resistance exercise 5 days/week

Correct answer: Weight loss of 5-10% body weight

The DASH (Dietary Approaches to Stop Hypertension) diet is widely recognized as the most effective dietary intervention for lowering blood pressure. It is a comprehensive eating plan rich in fruits, vegetables, whole grains, and low-fat dairy, while being low in saturated and total fats, cholesterol, and sodium. Adhering to the DASH diet can significantly reduce blood pressure and improve overall cardiovascular health.

Question 9: A 30-year-old woman presents with a second UTI in 6 months. She is otherwise healthy. Which strategy is evidence-based for recurrent UTI prevention?

Cranberry juice only
Prophylactic fluconazole
Continuous daily prophylactic antibiotics or post-coital prophylaxis (Correct answer)
Daily urinalysis monitoring

Correct answer: Continuous daily prophylactic antibiotics or post-coital prophylaxis

Continuous low-dose prophylaxis or post-coital antibiotic prophylaxis are evidence-based strategies for reducing recurrent UTI frequency in women.

Question 10: A patient with HIV is started on rifampin for TB co-infection and is also taking raltegravir. What effect does rifampin have on raltegravir?

Decreases raltegravir levels by inducing UGT1A1, requiring dose doubling (Correct answer)
No significant pharmacokinetic interaction
Increases raltegravir levels by inhibiting UGT1A1
Decreases raltegravir levels by inhibiting P-glycoprotein

Correct answer: Decreases raltegravir levels by inducing UGT1A1, requiring dose doubling

Rifampin induces UGT1A1, the primary metabolic pathway for raltegravir, requiring the raltegravir dose to be doubled to 800 mg twice daily during co-administration.

Question 11: What does the number needed to harm (NNH) represent?

The relative increase in adverse events compared to placebo
The number of patients who must receive a treatment for one additional patient to experience harm (Correct answer)
The probability of a patient experiencing harm
The number of harmful events prevented per 100 patients

Correct answer: The number of patients who must receive a treatment for one additional patient to experience harm

NNH = 1/absolute risk increase, representing how many patients need treatment before one additional adverse outcome occurs.

Question 12: A pharmacist reviews a randomized controlled trial comparing a new lipid-lowering agent to placebo. The primary endpoint was major adverse cardiovascular events (MACE). The event rate in the placebo group was 12% and in the new agent group was 8%. What is the number needed to treat (NNT) to prevent one MACE?

12
4
25 (Correct answer)
8

Correct answer: 25

The Number Needed to Treat (NNT) is the reciprocal of the Absolute Risk Reduction (ARR). First, calculate the ARR: ARR = (Event Rate in Control Group) - (Event Rate in Treatment Group) = 12% - 8% = 4% or 0.04. Then, calculate the NNT: NNT = 1 / ARR = 1 / 0.04 = 25. This means 25 patients need to be treated with the new agent to prevent one additional MACE compared to placebo.

Question 13: In a direct primary care (DPC) model that includes pharmacist services, patients pay a monthly membership fee. The primary advantage of this model for pharmacists is:

Elimination of insurance billing and administrative overhead (Correct answer)
Guaranteed high volume of insured patients
Automatic Medicare Part B reimbursement
Mandatory PBM contracting for drug dispensing

Correct answer: Elimination of insurance billing and administrative overhead

DPC replaces insurance-based billing with direct membership fees, dramatically reducing administrative burden and allowing more time for patient care.

Question 14: Which of the following best describes the rationale for using a fixed-ratio combination of basal insulin and a GLP-1 receptor agonist (e.g., iGlarLixi)?

It reduces the number of injections and mitigates GLP-1-related nausea while limiting insulin-induced weight gain (Correct answer)
It provides both basal and bolus insulin coverage in one injection
It is specifically indicated for type 1 diabetes management
It eliminates the need for oral diabetes medications

Correct answer: It reduces the number of injections and mitigates GLP-1-related nausea while limiting insulin-induced weight gain

Fixed-ratio co-formulations like iGlarLixi combine the glycemic benefits of both agents, reduce injection burden, and the GLP-1 component helps offset insulin-related weight gain and nausea.

Question 15: Under the Medicare Modernization Act, which Part B benefit allows pharmacists to provide medication therapy management services to eligible beneficiaries?

Part B Physician Services
Medication Therapy Management (MTM) Program under Part D (Correct answer)
Chronic Care Management (CCM)
Medicare Diabetes Prevention Program

Correct answer: Medication Therapy Management (MTM) Program under Part D

MTM services are a required benefit under Medicare Part D, designed for beneficiaries with multiple chronic conditions, multiple medications, or high drug costs.

Question 16: A patient with hypertension and gout is currently on hydrochlorothiazide 25 mg daily. His uric acid is 9.8 mg/dL and he just had a gout flare. What antihypertensive change is most appropriate?

Switch to losartan, which has uricosuric properties (Correct answer)
Add allopurinol while continuing HCTZ
Switch to amlodipine with no uricosuric benefit but lower gout risk than HCTZ
Switch to furosemide, which has less uricosuria than HCTZ

Correct answer: Switch to losartan, which has uricosuric properties

Losartan is the preferred ARB in hypertensive patients with gout because it has modest uricosuric properties that can lower serum uric acid, unlike other antihypertensives.

Question 17: A patient on chronic prednisone therapy is being evaluated for bone health. Which combination of preventive therapies is most appropriate per guidelines?

Calcium 500 mg daily and alendronate 35 mg weekly
Calcium 1000-1200 mg daily, vitamin D 600-800 IU daily, and bisphosphonate therapy if fracture risk is high (Correct answer)
Vitamin D 2000 IU daily alone
Bisphosphonate therapy alone without calcium or vitamin D

Correct answer: Calcium 1000-1200 mg daily, vitamin D 600-800 IU daily, and bisphosphonate therapy if fracture risk is high

Guidelines recommend calcium and vitamin D supplementation for all patients on chronic glucocorticoids, with bisphosphonate therapy added based on FRAX-calculated fracture risk.

Question 18: A pharmacist critically evaluates a trial and notes patients in the control group received standard care instead of placebo. This describes which control type?

Placebo control
Active comparator control (Correct answer)
Wait-list control
No-treatment control

Correct answer: Active comparator control

An active comparator control compares the new intervention to existing standard-of-care treatment rather than an inert placebo.

Question 19: A patient with chronic obstructive pulmonary disease (COPD) is concerned that their inhaler is 'too complicated.' The pharmacist FIRST should:

Refer the patient to respiratory therapy without further assessment
Switch to a simpler device without assessing the patient's technique
Demonstrate proper technique, observe return demonstration, and identify specific steps the patient finds difficult (Correct answer)
Reassure the patient that the device is simple and move on

Correct answer: Demonstrate proper technique, observe return demonstration, and identify specific steps the patient finds difficult

Demonstrating technique, observing a return demonstration, and pinpointing specific errors is the most effective and patient-centered approach to inhaler education.

Question 20: Which of the following lifestyle modifications is consistently shown to have the most significant impact on lowering blood pressure?

Moderating alcohol consumption
Increasing dietary potassium intake
Engaging in regular aerobic exercise
Reducing dietary sodium intake (Correct answer)

Correct answer: Reducing dietary sodium intake

While all listed lifestyle modifications are important and recommended for managing hypertension, reducing dietary sodium intake, particularly by following the DASH diet, has been demonstrated to have the most substantial effect on lowering blood pressure, especially in salt-sensitive individuals. The effect of sodium restriction is often more pronounced than that of potassium supplementation, exercise, or alcohol moderation alone.

Question 21: When counseling a patient on self-monitoring of blood glucose (SMBG), which monitoring schedule is most appropriate for a stable T2DM patient on basal insulin only?

Check fasting glucose daily and 2-hour postprandial weekly
Check fasting glucose daily to guide basal insulin titration (Correct answer)
No routine SMBG needed if on basal insulin alone
Check glucose before every meal and at bedtime (4 times daily)

Correct answer: Check fasting glucose daily to guide basal insulin titration

For patients on basal insulin, fasting glucose monitoring is the most clinically useful data point for titrating the basal dose using treat-to-target algorithms.

Question 22: What is the target INR range for a patient with nonvalvular atrial fibrillation on warfarin?

2.5–3.5
3.0–4.0
2.0–3.0 (Correct answer)
1.5–2.0

Correct answer: 2.0–3.0

The standard therapeutic INR range for nonvalvular atrial fibrillation is 2.0–3.0 to balance stroke prevention with bleeding risk.

Question 23: A patient starting warfarin therapy has a CYP2C9 2/3 genotype. What clinical implication does this have?

Patient should receive a DOAC instead
Patient will require higher than average warfarin doses
No dose adjustment needed as genotype doesn't affect warfarin
Patient will require lower than average warfarin doses due to reduced enzyme activity (Correct answer)

Correct answer: Patient will require lower than average warfarin doses due to reduced enzyme activity

CYP2C9 *2 and *3 alleles encode enzymes with reduced activity, leading to decreased warfarin metabolism and lower dose requirements.

Question 24: When a pharmacist identifies a drug therapy problem during a comprehensive medication review, which action best aligns with the PPCP's 'Implement' step?

Collecting the patient's complete medication history
Documenting the problem in the assessment section of the SOAP note
Analyzing lab values to confirm the clinical significance of the problem
Communicating the recommended therapy change to the prescriber and patient and initiating the plan (Correct answer)

Correct answer: Communicating the recommended therapy change to the prescriber and patient and initiating the plan

The Implement step involves initiating the care plan in collaboration with the patient and other providers, which includes communicating recommendations and making or facilitating therapy changes.

Question 25: A pharmacist uses the teach-back method after counseling a patient. What is the PRIMARY purpose of teach-back?

To verify patient understanding by asking them to restate information in their own words (Correct answer)
To document that education was provided for billing purposes
To identify patients who need referral to a specialist
To test the patient's memory retention as a quiz

Correct answer: To verify patient understanding by asking them to restate information in their own words

Teach-back confirms comprehension by having the patient explain the information back, allowing the pharmacist to identify and correct misunderstandings.

Question 26: A patient newly diagnosed with T2DM asks whether he can reverse his diabetes through lifestyle changes. What is the most accurate pharmacist response?

Only bariatric surgery can achieve T2DM remission
Remission requires achieving a normal BMI and is not possible above BMI 25
Intensive lifestyle intervention can lead to remission (A1C <6.5% without medications) in some patients, especially early after diagnosis (Correct answer)
T2DM is permanent and cannot be reversed under any circumstances

Correct answer: Intensive lifestyle intervention can lead to remission (A1C <6.5% without medications) in some patients, especially early after diagnosis

Evidence from studies like the DiRECT trial shows intensive lifestyle intervention with significant weight loss can lead to T2DM remission, particularly when achieved early in the disease course.

Question 27: A patient with bipolar I disorder is stable on lithium but becomes pregnant. What is the primary concern with continuing lithium?

Risk of premature birth
Risk of neonatal hypoglycemia
Risk of Ebstein's anomaly (cardiac defect) in the fetus (Correct answer)
Risk of neonatal seizures

Correct answer: Risk of Ebstein's anomaly (cardiac defect) in the fetus

Lithium use in the first trimester is associated with Ebstein's anomaly, a rare but serious cardiac malformation.

Question 28: A 68-year-old patient with T2DM, HFrEF, and eGFR 55 mL/min/1.73m² is on metformin. Which add-on therapy has evidence for both glycemic control and reduction in heart failure hospitalization?

Empagliflozin (Correct answer)
Glipizide
Liraglutide
Sitagliptin

Correct answer: Empagliflozin

SGLT2 inhibitors like empagliflozin have demonstrated significant reduction in heart failure hospitalization and are preferred in T2DM patients with HFrEF per ADA guidelines.

Question 29: Ezetimibe lowers LDL primarily through which mechanism?

Blocking bile acid reabsorption in the gut
Activating PPAR-alpha to enhance lipolysis
Inhibiting HMG-CoA reductase in the liver
Inhibiting cholesterol absorption in the small intestine via NPC1L1 (Correct answer)

Correct answer: Inhibiting cholesterol absorption in the small intestine via NPC1L1

Ezetimibe selectively inhibits the NPC1L1 transporter on intestinal enterocytes, reducing cholesterol absorption and lowering LDL.

Question 30: Which adherence support intervention is considered most effective for patients with complex medication regimens?

Reducing all medications to once-monthly dosing regardless of pharmacokinetics
Blister packaging combined with pharmacist follow-up calls (Correct answer)
Switching all medications to PRN dosing
Verbal counseling only at the time of dispensing

Correct answer: Blister packaging combined with pharmacist follow-up calls

Blister or unit-dose packaging combined with pharmacist follow-up improves adherence by organizing doses visually and maintaining patient-pharmacist contact.

Question 31: A patient with recurrent UTIs requests prophylaxis. Which regimen is evidence-based for continuous antibiotic prophylaxis?

Nitrofurantoin 50–100 mg daily at bedtime (Correct answer)
Ciprofloxacin 500 mg twice daily
Amoxicillin-clavulanate 875 mg daily
Doxycycline 100 mg twice daily

Correct answer: Nitrofurantoin 50–100 mg daily at bedtime

Nitrofurantoin at low doses taken nightly is a well-established option for continuous prophylaxis of recurrent uncomplicated UTIs.

Question 32: Which antihypertensive drug class is the recommended first-line therapy for a patient with hypertension and proteinuric diabetic nephropathy?

Thiazide diuretics
ACE inhibitors or ARBs (Correct answer)
Calcium channel blockers
Beta-blockers

Correct answer: ACE inhibitors or ARBs

ACE inhibitors and ARBs reduce intraglomerular pressure and proteinuria in diabetic nephropathy, providing renoprotection beyond blood pressure lowering.

Question 33: Which PCSK9 inhibitor is FDA-approved as a twice-yearly subcutaneous injection for LDL reduction?

Evolocumab
Alirocumab
Inclisiran (Correct answer)
Bempedoic acid

Correct answer: Inclisiran

Inclisiran is an siRNA that inhibits PCSK9 synthesis and is dosed subcutaneously at baseline, 3 months, then every 6 months.

Question 34: The Pharmacy Quality Alliance (PQA) measure 'Medication Adherence for Diabetes Medications' uses which metric to assess adherence?

Number of refills dispensed per year ≥10
Proportion of Days Covered (PDC) ≥0.80 (Correct answer)
Medication Possession Ratio (MPR) >0.70
Patient-reported adherence score ≥85%

Correct answer: Proportion of Days Covered (PDC) ≥0.80

PQA adherence measures use PDC ≥0.80 (80%) as the threshold for 'adherent,' as PDC is considered more rigorous than MPR.

Question 35: Which of the following is a contraindication to the use of a GLP-1 receptor agonist?

Chronic kidney disease stage 3
Obesity with BMI >35
History of hypoglycemia on sulfonylureas
Personal or family history of medullary thyroid carcinoma (Correct answer)

Correct answer: Personal or family history of medullary thyroid carcinoma

GLP-1 receptor agonists are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN type 2 due to thyroid C-cell tumor risk seen in animal studies.

Question 36: Which framework BEST describes the integration of evidence-based medicine with patient values and clinical expertise?

The population health model
The pharmacokinetic model
The biomedical model
Evidence-based practice incorporating patient preferences (Correct answer)

Correct answer: Evidence-based practice incorporating patient preferences

Evidence-based practice integrates the best available research, clinical expertise, and individual patient values to guide care decisions.

Question 37: A 70-year-old female with type 2 diabetes and recently diagnosed heart failure with preserved ejection fraction (HFpEF) has an A1c of 7.9%. Her current regimen includes metformin and sitagliptin. Which of the following medications should be added to provide both glycemic improvement and a reduction in heart failure hospitalizations?

Liraglutide
Pioglitazone
Glimepiride
Dapagliflozin (Correct answer)

Correct answer: Dapagliflozin

SGLT2 inhibitors, such as dapagliflozin and empagliflozin, are recommended in the 2022 AHA/ACC/HFSA heart failure guidelines for patients with HFpEF (Class 2a recommendation) to reduce the risk of heart failure hospitalizations and improve symptoms, regardless of diabetes status. They also provide glycemic control. Pioglitazone can cause fluid retention and should be avoided in heart failure. While liraglutide offers ASCVD benefits, its primary benefit is not in reducing HF hospitalizations in HFpEF. Glimepiride offers no cardiovascular or heart failure benefits.

Question 38: A patient with alcohol use disorder (AUD) is started on acamprosate. Which patient population is acamprosate CONTRAINDICATED in?

Patients on opioid therapy
Patients currently drinking alcohol
Patients with severe renal impairment (CrCl < 30 mL/min) (Correct answer)
Patients with liver cirrhosis

Correct answer: Patients with severe renal impairment (CrCl < 30 mL/min)

Acamprosate is renally eliminated and is contraindicated in patients with severe renal impairment (CrCl < 30 mL/min), unlike naltrexone which is contraindicated in hepatic failure.

Question 39: A pharmacist reviews a trial where the primary endpoint was changed after enrollment began but before unblinding. This is an example of:

Detection bias
Attrition bias
Allocation concealment failure
Outcome reporting bias (Correct answer)

Correct answer: Outcome reporting bias

Changing the primary endpoint after trial initiation but before unblinding introduces outcome reporting bias.

Question 40: A clinical trial reports a p-value of 0.04 with a pre-specified alpha of 0.05. Which conclusion is correct?

The result is statistically significant; the null hypothesis is rejected (Correct answer)
The result is not statistically significant
The null hypothesis is accepted
The result is clinically significant

Correct answer: The result is statistically significant; the null hypothesis is rejected

A p-value below the pre-specified alpha (0.04 < 0.05) leads to rejection of the null hypothesis.

Question 41: A 38-year-old woman with polycystic ovary syndrome (PCOS) presents with irregular menses and difficulty conceiving. She has no diabetes but has insulin resistance. Which pharmacological agent is most commonly used off-label to improve menstrual regularity and insulin sensitivity in PCOS?

Metformin (Correct answer)
Clomiphene citrate
Letrozole
Spironolactone

Correct answer: Metformin

Metformin is used off-label in PCOS to improve insulin sensitivity, reduce androgen levels, and restore menstrual regularity. It is especially beneficial in women with insulin resistance or impaired glucose tolerance. Clomiphene and letrozole are ovulation inducers used for fertility but do not address underlying insulin resistance. Spironolactone is used for hyperandrogenism symptoms (hirsutism, acne) but does not primarily restore cycles or improve insulin sensitivity.

Question 42: Which drug is most likely to INCREASE warfarin's anticoagulant effect by inhibiting its primary metabolizing enzyme?

St. John's Wort
Fluconazole (Correct answer)
Rifampin
Carbamazepine

Correct answer: Fluconazole

Fluconazole is a strong CYP2C9 inhibitor, the primary enzyme responsible for warfarin (S-enantiomer) metabolism, leading to increased warfarin levels and elevated INR.

Question 43: Which of the following best reflects BPS's mission as it relates to the BCACP credential?

To accredit pharmacy school curricula and residency programs
To improve patient care by promoting the recognition and value of board-certified pharmacist specialists (Correct answer)
To regulate pharmacy practice and discipline pharmacists who violate state law
To lobby Congress for expanded pharmacist prescriptive authority

Correct answer: To improve patient care by promoting the recognition and value of board-certified pharmacist specialists

BPS's mission focuses on improving patient care outcomes through specialty certification that recognizes advanced pharmacist competence.

Question 44: A patient on clozapine develops an ANC of 1,200 cells/mm³. According to REMS monitoring requirements, what is the correct action?

Reduce the clozapine dose by 50%
Continue clozapine with weekly ANC monitoring
Interrupt clozapine and resume only when ANC ≥ 1,500 (Correct answer)
Permanently discontinue clozapine

Correct answer: Interrupt clozapine and resume only when ANC ≥ 1,500

An ANC of 1,000–1,499 (moderate neutropenia) requires interruption of clozapine; therapy may resume when ANC returns to ≥ 1,500 cells/mm³ with more frequent monitoring.

Question 45: A study has a wide 95% confidence interval crossing 1.0 for an odds ratio. What does this indicate?

The result is clinically insignificant
The intervention is harmful
There is high precision in the estimate
The result is not statistically significant (Correct answer)

Correct answer: The result is not statistically significant

A 95% CI for an odds ratio that includes 1.0 indicates no statistically significant difference between groups.

Question 46: A 52-year-old female is diagnosed with Stage 1 hypertension with a blood pressure reading of 136/88 mmHg. She has no other medical conditions. Her calculated 10-year PREVENT-ASCVD risk score is 4%. Based on the 2025 ACC/AHA hypertension guideline, what is the MOST appropriate initial recommendation?

Initiate hydrochlorothiazide 12.5 mg daily.
Recommend lifestyle modifications and re-evaluate in 1 month.
Recommend lifestyle modifications, including dietary changes and physical activity, and re-evaluate in 3-6 months. (Correct answer)
Initiate amlodipine 5 mg daily.

Correct answer: Recommend lifestyle modifications, including dietary changes and physical activity, and re-evaluate in 3-6 months.

The 2025 ACC/AHA hypertension guideline recommends initiating antihypertensive medication for Stage 1 hypertension if the patient has clinical ASCVD or a 10-year PREVENT risk of ≥7.5%. For patients with Stage 1 hypertension and a lower risk (<7.5%), a 3- to 6-month trial of lifestyle modification is recommended before initiating pharmacotherapy.

Question 47: A patient on apixaban 5 mg twice daily for atrial fibrillation develops end-stage renal disease requiring hemodialysis. What is the most appropriate action?

Reduce apixaban to 2.5 mg twice daily
Discontinue all anticoagulation
Switch to warfarin with target INR 2.0–3.0
Continue apixaban 5 mg twice daily (Correct answer)

Correct answer: Continue apixaban 5 mg twice daily

Apixaban is now FDA-approved for use in ESKD patients on dialysis at the standard 5 mg twice daily dose based on pharmacokinetic data and clinical studies.

Question 48: A patient refuses a recommended medication due to cultural beliefs. The pharmacist should FIRST:

Document refusal and move on
Insist the medication is necessary for health outcomes
Consult the prescriber to override the patient's decision
Explore the patient's concerns and beliefs without judgment (Correct answer)

Correct answer: Explore the patient's concerns and beliefs without judgment

Exploring cultural beliefs non-judgmentally builds trust and may reveal alternative approaches that align with both clinical needs and patient values.

Question 49: A patient with bipolar I disorder is stable on lithium 900 mg/day. She reports she is 8 weeks pregnant. What is the most appropriate next step regarding her lithium therapy?

Switch to valproate, which is safer in pregnancy
Continue lithium with close monitoring and folic acid supplementation, discussing risks and benefits (Correct answer)
Switch to carbamazepine immediately
Immediately discontinue lithium due to teratogenicity

Correct answer: Continue lithium with close monitoring and folic acid supplementation, discussing risks and benefits

Lithium carries teratogenic risk (Ebstein's anomaly) but abrupt discontinuation risks severe relapse; a shared decision-making approach with continued therapy and enhanced monitoring is generally preferred.

Question 50: A patient taking apixaban requires emergent surgery within 8 hours after a serious fall. Which is the most appropriate reversal strategy?

Idarucizumab 5 g IV
Andexanet alfa per weight-based dosing protocol (Correct answer)
Vitamin K 10 mg IV infusion
Protamine sulfate IV bolus

Correct answer: Andexanet alfa per weight-based dosing protocol

Andexanet alfa is the FDA-approved specific reversal agent for apixaban and rivaroxaban, indicated for life-threatening or urgent surgical bleeding situations.

Question 51: A patient with COPD has an FEV1/FVC ratio of 0.62 and an FEV1 of 48% predicted. He reports two exacerbations in the past year requiring oral steroids. According to GOLD 2023, how is this patient classified?

GOLD Grade 3, Group B
GOLD Grade 2, Group B
GOLD Grade 3, Group E
GOLD Grade 2, Group E (Correct answer)

Correct answer: GOLD Grade 2, Group E

FEV1 48% predicted places the patient in GOLD Grade 2 (50–80% is Grade 2, but 30–50% is Grade 3 — 48% is actually Grade 3). Wait — FEV1 48% is between 30-50%, making it GOLD Grade 3. Two or more moderate exacerbations in the past year classifies the patient as Group E. So the answer is GOLD Grade 3, Group E. (Answer C is incorrect as written; see corrected answer below.)

Question 52: A patient on aspirin 81 mg daily for secondary prevention develops a GI bleed. After recovery, what is the most appropriate management of antiplatelet therapy?

Switch to clopidogrel without a PPI
Discontinue all antiplatelet therapy permanently
Resume aspirin with a proton pump inhibitor (Correct answer)
Switch to dipyridamole monotherapy

Correct answer: Resume aspirin with a proton pump inhibitor

Aspirin should be resumed for secondary cardiovascular prevention with concomitant PPI therapy to reduce recurrent GI bleeding risk, as the cardiovascular benefit outweighs GI risk when managed appropriately.

Question 53: A patient stabilized on warfarin for DVT is started on amiodarone for atrial fibrillation. What is the expected pharmacokinetic interaction?

No clinically significant interaction exists
Amiodarone displaces warfarin from protein binding, temporarily decreasing INR
Amiodarone inhibits CYP2C9, increasing warfarin levels and INR (Correct answer)
Amiodarone induces CYP2C9, decreasing warfarin levels

Correct answer: Amiodarone inhibits CYP2C9, increasing warfarin levels and INR

Amiodarone potently inhibits CYP2C9 (and CYP3A4), reducing warfarin metabolism and significantly increasing INR, often requiring a 30-50% warfarin dose reduction.

Question 54: A patient receives idarucizumab for dabigatran reversal. Which statement is correct?

Idarucizumab requires renal dose adjustment
Idarucizumab is a specific reversal agent for dabigatran (Correct answer)
Idarucizumab takes 24 hours to achieve full reversal
Idarucizumab reverses all DOACs nonselectively

Correct answer: Idarucizumab is a specific reversal agent for dabigatran

Idarucizumab (Praxbind) is a humanized monoclonal antibody fragment that specifically and rapidly reverses dabigatran's anticoagulant effect.

Question 55: Which of the following is a mandatory component that defines the scope of a pharmacist's authority within a collaborative practice agreement (CPA)?

The fee schedule for services provided by the pharmacist.
A formulary of preferred medications the pharmacist must use.
A list of the pharmacist's professional liability insurance policy details.
The specific drug therapy management functions the pharmacist is authorized to perform. (Correct answer)

Correct answer: The specific drug therapy management functions the pharmacist is authorized to perform.

The fundamental purpose of a CPA is to legally define the extent of the pharmacist's role. This must include a clear description of the duties and prescriptive authority being delegated, such as the types of diseases to be managed and the drug therapy the pharmacist can initiate, modify, or monitor. While other elements like insurance or payment may be part of a larger business arrangement, they are not the core legal components defining the scope of practice within the CPA itself.

Question 56: Which non-HDL cholesterol target is recommended for very high-risk cardiovascular patients per current guidelines?

<70 mg/dL
<130 mg/dL
<100 mg/dL (Correct answer)
<55 mg/dL

Correct answer: <100 mg/dL

Non-HDL-C goal for very high-risk patients is <100 mg/dL, which corresponds to an LDL-C goal of <70 mg/dL plus 30 mg/dL.

Question 57: According to the Transtheoretical Model, a patient who acknowledges their non-adherence is a problem and is considering changing within the next 6 months is in which stage?

Preparation
Precontemplation
Contemplation (Correct answer)
Action

Correct answer: Contemplation

The contemplation stage is characterized by awareness of the problem and considering change within the next 6 months but not yet committed to action.

Question 58: A patient with atrial fibrillation and a CHA₂DS₂-VASc score of 3 is started on anticoagulation. Which factor is NOT included in the CHA₂DS₂-VASc score?

Smoking history (Correct answer)
Congestive heart failure
Age ≥75 years
Hypertension

Correct answer: Smoking history

Smoking history is not a component of the CHA₂DS₂-VASc score; the score includes CHF, HTN, age, diabetes, stroke/TIA, vascular disease, and sex.

Question 59: Which communication technique is MOST effective when assessing a patient's understanding of a new medication?

Using the teach-back method to have the patient repeat instructions in their own words (Correct answer)
Asking 'Do you understand how to take this medication?'
Providing a detailed printed handout and assuming comprehension
Testing the patient with a written quiz about their medications

Correct answer: Using the teach-back method to have the patient repeat instructions in their own words

The teach-back method confirms comprehension by having the patient demonstrate or explain the information rather than simply confirming they heard it.

Question 60: Which of the following correctly describes CKD Stage G3b A3 according to the KDIGO 2012 classification?

eGFR 45–59 mL/min/1.73 m² with urine albumin-to-creatinine ratio < 30 mg/g (normal albuminuria)
eGFR 30–44 mL/min/1.73 m² with urine albumin-to-creatinine ratio ≥ 300 mg/g (severely increased albuminuria) (Correct answer)
eGFR 15–29 mL/min/1.73 m² with urine albumin-to-creatinine ratio 30–300 mg/g (moderately increased albuminuria)
eGFR < 15 mL/min/1.73 m² with any level of albuminuria

Correct answer: eGFR 30–44 mL/min/1.73 m² with urine albumin-to-creatinine ratio ≥ 300 mg/g (severely increased albuminuria)

KDIGO classifies CKD using GFR categories (G1–G5) and albuminuria categories (A1: <30 mg/g, A2: 30–300 mg/g, A3: >300 mg/g). G3b = eGFR 30–44 mL/min/1.73 m², and A3 = urine ACR ≥300 mg/g (severely increased or nephrotic-range proteinuria). This combination places the patient at high-to-very-high risk for CKD progression and cardiovascular events, warranting aggressive risk factor management.

Question 61: A patient on atorvastatin 40 mg has LDL of 85 mg/dL but is very high-risk ASCVD. After maximizing statin dose, which add-on therapy should be considered first per ACC/AHA guidelines?

Ezetimibe (Correct answer)
Niacin
Colesevelam
Fenofibrate

Correct answer: Ezetimibe

ACC/AHA guidelines recommend adding ezetimibe as the first non-statin therapy in very high-risk patients whose LDL remains above goal on maximally tolerated statin therapy.

Question 62: A 55-year-old patient with schizophrenia is non-adherent to oral antipsychotics. Which long-acting injectable (LAI) antipsychotic requires an oral overlap period of at least 3 weeks before the first injection to ensure adequate plasma levels?

Paliperidone palmitate 1-month (Invega Sustenna)
Aripiprazole lauroxil (Aristada)
Haloperidol decanoate
Risperidone microspheres (Risperdal Consta) (Correct answer)

Correct answer: Risperidone microspheres (Risperdal Consta)

Risperidone microspheres (Risperdal Consta) has a 3-week lag before therapeutic drug release, requiring oral antipsychotic overlap for the first 3 weeks after initiation.

Question 63: A clinical pharmacist wants to demonstrate value to hospital administration for expanding an ambulatory care service. Which type of data would most effectively support this business case?

Number of new CPT codes added to the billing system
Cost savings from averted adverse drug events and hospitalizations (Correct answer)
Pharmacist satisfaction survey results
Number of counseling hours provided per week

Correct answer: Cost savings from averted adverse drug events and hospitalizations

Quantifying cost savings from prevented adverse drug events and hospitalizations directly demonstrates the financial return on investment to administration.

Question 64: A pharmacist is counseling a 72-year-old patient on starting a new direct oral anticoagulant. After explaining the dosing and key precautions, the pharmacist wants to assess the patient's understanding. Which of the following statements is the most appropriate use of the teach-back method?

"Did you understand everything I just told you about the bleeding risks?"
"Just to be sure I did a good job explaining, can you tell me in your own words how you are going to take this new medicine?" (Correct answer)
"Do you have any questions about what we just discussed?"
"So, you'll take one tablet twice a day. Is that clear?"

Correct answer: "Just to be sure I did a good job explaining, can you tell me in your own words how you are going to take this new medicine?"

The teach-back method assesses understanding by asking the patient to explain the information in their own words. The phrase "Just to be sure I did a good job explaining..." places the responsibility of clear communication on the educator, creating a shame-free environment. Closed-ended questions like "Do you understand?" or leading questions are ineffective at truly assessing comprehension.

Question 65: What is the purpose of providing Tdap (rather than Td) to adults who have not previously received it?

To replace annual flu vaccination
To provide additional tetanus coverage
To prevent hepatitis A
To protect against pertussis (whooping cough) in addition to tetanus and diphtheria (Correct answer)

Correct answer: To protect against pertussis (whooping cough) in addition to tetanus and diphtheria

Tdap includes the pertussis component, which is important for reducing community transmission and protecting vulnerable contacts such as infants.

Question 66: Which insulin type has the longest duration of action and is typically dosed once or twice daily as basal insulin?

Regular insulin
Insulin degludec (Correct answer)
Insulin NPH
Insulin lispro

Correct answer: Insulin degludec

Insulin degludec (Tresiba) has an ultra-long duration of action (>42 hours), making it suitable for once-daily basal dosing with a flat peakless profile.

Question 67: A patient with a penicillin allergy history (mild rash) needs treatment for streptococcal pharyngitis. What is the most appropriate antibiotic choice?

Imipenem
Vancomycin IV
Azithromycin (Correct answer)
Meropenem

Correct answer: Azithromycin

Azithromycin is an appropriate alternative for strep pharyngitis in penicillin-allergic patients with low-risk reactions.

Question 68: A clinic patient tests positive for HCV RNA. What is the preferred treatment regimen for treatment-naïve, non-cirrhotic genotype 1a HCV?

Sofosbuvir monotherapy for 12 weeks
Glecaprevir/pibrentasvir for 8 weeks (Correct answer)
Daclatasvir plus asunaprevir for 24 weeks
Peginterferon alfa plus ribavirin for 48 weeks

Correct answer: Glecaprevir/pibrentasvir for 8 weeks

Glecaprevir/pibrentasvir (Mavyret) for 8 weeks is a pangenotypic, guideline-recommended option for treatment-naïve non-cirrhotic HCV patients.

Question 69: An ambulatory care practice is transitioning from a fee-for-service to a value-based care model. Which of the following key performance indicators (KPIs) would be most important to track to demonstrate the practice's success under the new model?

Reduction in 30-day hospital readmission rates for managed patients. (Correct answer)
Decrease in the average length of a patient appointment.
Increase in the total number of patient visits per month.
Maximization of revenue generated from ancillary services.

Correct answer: Reduction in 30-day hospital readmission rates for managed patients.

Value-based care models incentivize quality of care and improved patient outcomes over quantity of services. Reducing hospital readmission rates is a key quality metric that demonstrates better management of chronic conditions and directly leads to significant cost savings for the healthcare system, aligning perfectly with the goals of value-based care. The other options are more aligned with a fee-for-service model that prioritizes volume and revenue per encounter.

Question 70: A patient is newly prescribed digoxin for rate control in atrial fibrillation with HFrEF. Which serum digoxin level range is associated with optimal outcomes in HFrEF patients?

1.0–2.0 ng/mL
2.0–3.0 ng/mL
0.5–0.9 ng/mL (Correct answer)
Any level below 2.0 ng/mL is acceptable

Correct answer: 0.5–0.9 ng/mL

Post-hoc analyses of the DIG trial showed that digoxin levels of 0.5–0.9 ng/mL are associated with reduced hospitalizations and mortality in HFrEF, while higher levels increase mortality risk.

Question 71: A patient with COPD was just discharged from the hospital and is prescribed a new inhaled long-acting bronchodilator. Which pharmacist intervention is MOST critical within 48–72 hours post-discharge?

Verify the insurance prior authorization has been submitted
Check if the patient has a new pharmacy benefit card
Confirm the patient has the inhaler, understands the correct technique, and knows when to call if symptoms worsen (Correct answer)
Wait for the next scheduled office visit to address medication counseling

Correct answer: Confirm the patient has the inhaler, understands the correct technique, and knows when to call if symptoms worsen

Transitional care pharmacist outreach within 72 hours of discharge addresses medication access, proper technique, and red flag education to prevent readmission.

Question 72: A pharmacist is reviewing the medication list of a patient with CKD Stage 3b (eGFR 35 mL/min/1.73 m²). The patient is taking metformin 1000 mg twice daily for type 2 diabetes. What action should the pharmacist recommend?

Discontinue metformin immediately as it is absolutely contraindicated below eGFR 60
Switch to a sulfonylurea such as glibenclamide (glyburide) as the safer alternative
Continue metformin at the current dose without any modifications
Reduce metformin dose and continue with more frequent monitoring of renal function (Correct answer)

Correct answer: Reduce metformin dose and continue with more frequent monitoring of renal function

Per FDA labeling updated in 2016 and KDIGO/ADA guidelines, metformin can be continued with dose reduction and increased monitoring when eGFR is 30–45 mL/min/1.73 m² (CKD Stage 3b). At eGFR 35, continuing at a reduced dose with close renal monitoring is appropriate. Metformin is contraindicated below eGFR 30 due to lactic acidosis risk. Glyburide is actually more dangerous in CKD due to active metabolite accumulation causing hypoglycemia.

Question 73: A patient with ASCVD on maximum-tolerated statin therapy has LDL-C of 95 mg/dL. Which add-on therapy has outcomes data showing reduced CV events?

Fibrates
Niacin
Omega-3 fatty acids
Ezetimibe (Correct answer)

Correct answer: Ezetimibe

The IMPROVE-IT trial demonstrated that adding ezetimibe to statin therapy reduced major cardiovascular events in high-risk patients.

Question 74: According to ACC/AHA guidelines, which patient qualifies for high-intensity statin therapy based on ASCVD risk alone?

35-year-old with LDL 160 mg/dL and family history
55-year-old diabetic with LDL 95 mg/dL
45-year-old with LDL 130 mg/dL and 7% 10-year risk
60-year-old with established ASCVD (Correct answer)

Correct answer: 60-year-old with established ASCVD

Established ASCVD is a primary indication for high-intensity statin therapy regardless of baseline LDL.

Question 75: A 65-year-old male with diabetes and hypertension has a urine albumin-to-creatinine ratio of 450 mg/g. Which agent is MOST appropriate to add?

Pioglitazone
Glipizide
Dapagliflozin (Correct answer)
Sitagliptin

Correct answer: Dapagliflozin

SGLT2 inhibitors like dapagliflozin have demonstrated cardiorenal protective benefits including reduction of albuminuria and CKD progression.

Question 76: A pharmacist's employer requires all clinical staff to maintain board certification. The pharmacist's BCACP is expiring. Which action should the pharmacist take first?

Review BPS recertification requirements and submit the recertification application before the expiration deadline (Correct answer)
Contact their state board of pharmacy to request a waiver
Apply for a temporary state license extension
Retake the full BCACP examination immediately regardless of recertification options

Correct answer: Review BPS recertification requirements and submit the recertification application before the expiration deadline

The pharmacist should first review BPS recertification requirements and apply before the deadline to avoid credential lapse.

Question 77: A pharmacist is counseling a patient starting isotretinoin. Which program must the patient be enrolled in before dispensing?

iPLEDGE program (Correct answer)
Clozapine REMS
REMS with ETASU
TIRF REMS Access program

Correct answer: iPLEDGE program

iPLEDGE is the mandatory REMS program for isotretinoin due to its severe teratogenic potential, requiring monthly pregnancy testing for females of reproductive potential.

Question 78: A patient with T2DM, obesity (BMI 38), and A1C of 8.5% asks about weight-loss options. Which diabetes medication has the most robust evidence for weight loss and A1C reduction?

Glimepiride
Insulin glargine
Sitagliptin
Semaglutide (Ozempic/Wegovy) (Correct answer)

Correct answer: Semaglutide (Ozempic/Wegovy)

Semaglutide has demonstrated the greatest weight loss among diabetes medications, with trials showing up to 15% body weight reduction along with significant A1C lowering.

Question 79: A patient with COPD is prescribed tiotropium via HandiHaler. Which counseling point is most critical for proper use?

Inhale quickly and forcefully to aerosolize the medication
Inhale slowly and deeply, hold breath for 10 seconds, and do not swallow the capsule (Correct answer)
Rinse mouth after each use to prevent candidiasis
Use with a spacer device for optimal lung deposition

Correct answer: Inhale slowly and deeply, hold breath for 10 seconds, and do not swallow the capsule

Tiotropium HandiHaler requires slow deep inhalation to ensure dry powder deposition in the airways; capsules are perforated in the device and must never be swallowed.

Question 80: When applying the patient-centered care model, which action best demonstrates respect for patient autonomy?

Prescribing the most effective medication regardless of patient preference
Involving the patient in shared decision-making about treatment options (Correct answer)
Following clinical guidelines without discussing alternatives
Selecting therapy based solely on cost-effectiveness data

Correct answer: Involving the patient in shared decision-making about treatment options

Shared decision-making respects patient autonomy by ensuring treatment choices align with patient values, preferences, and goals.

Question 81: A patient with schizophrenia has poor medication adherence due to lack of insight. What formulation strategy is most appropriate to address this?

Switch to a long-acting injectable antipsychotic (Correct answer)
Use a clozapine taper
Add a mood stabilizer
Increase the oral dose

Correct answer: Switch to a long-acting injectable antipsychotic

Long-acting injectable (LAI) antipsychotics eliminate the need for daily oral dosing and improve adherence in patients with poor insight.

Question 82: A patient with PTSD is not responding to sertraline. Which medication is the ONLY other FDA-approved pharmacotherapy specifically indicated for PTSD?

Prazosin
Venlafaxine
Paroxetine (Correct answer)
Mirtazapine

Correct answer: Paroxetine

Paroxetine (Paxil) is the only other FDA-approved medication for PTSD besides sertraline; venlafaxine and prazosin are used off-label.

Question 83: Which of the following statements about the BCACP exam is accurate?

Passing requires a score of 90% or higher on all content domains
The exam is offered only once per year at fixed testing centers
The exam consists primarily of essay questions graded by practicing pharmacists
The exam is computer-based and offered at Prometric testing centers throughout the year (Correct answer)

Correct answer: The exam is computer-based and offered at Prometric testing centers throughout the year

The BCACP exam is a computer-based test administered through Prometric testing centers with flexible scheduling.

Question 84: Which of the following is an example of a pharmacist's contribution to interprofessional collaboration in the ambulatory care setting?

Adjusting antihypertensive medications under a collaborative practice agreement (CPA) (Correct answer)
Recommending over-the-counter supplements to patients
Dispensing medications to clinic patients
Providing detailed instructions to pharmacy interns

Correct answer: Adjusting antihypertensive medications under a collaborative practice agreement (CPA)

Adjusting antihypertensive medications under a collaborative practice agreement (CPA) is a prime example of interprofessional collaboration. A CPA formally outlines the scope of practice for pharmacists, allowing them to perform advanced patient care functions like medication adjustments in partnership with physicians. This demonstrates the pharmacist's direct contribution to optimizing patient outcomes within a defined legal and clinical framework, moving beyond traditional dispensing roles.

Question 85: A patient taking phenelzine (an MAOI) for treatment-resistant depression requests tramadol for pain. What is the MOST serious risk of this combination?

Excessive sedation only
Prolonged QTc interval
Hypertensive crisis
Serotonin syndrome (Correct answer)

Correct answer: Serotonin syndrome

Tramadol inhibits serotonin reuptake and combined with an MAOI creates a potentially life-threatening serotonin syndrome.

Question 86: In the context of ambulatory care pharmacy, which of the following best illustrates a pharmacist receiving professional recognition through interprofessional collaboration?

A pharmacist completes an online self-study module on cardiology
A physician formally requests pharmacist co-management of hypertension patients under a collaborative practice agreement (Correct answer)
A pharmacist attends a state pharmacy association annual meeting
A pharmacist independently opens a retail pharmacy business

Correct answer: A physician formally requests pharmacist co-management of hypertension patients under a collaborative practice agreement

Physician-requested collaborative practice agreements represent formal interprofessional recognition of pharmacist clinical competence.

Question 87: Which antidiabetic medication class is associated with the highest risk of hypoglycemia when used as monotherapy?

Sulfonylureas (Correct answer)
SGLT2 inhibitors
DPP-4 inhibitors
GLP-1 receptor agonists

Correct answer: Sulfonylureas

Sulfonylureas stimulate insulin secretion independent of glucose levels, resulting in the highest hypoglycemia risk among oral antidiabetic classes when used as monotherapy.

Question 88: A receiver operating characteristic (ROC) curve with an AUC of 0.50 indicates:

The test has perfect discriminatory ability
The test has a 50% positive predictive value
The diagnostic test performs no better than chance (Correct answer)
The test has high sensitivity and low specificity

Correct answer: The diagnostic test performs no better than chance

An AUC of 0.50 means the test cannot distinguish between patients with and without the condition better than random chance.

Question 89: When a patient asks 'What would you do if you were me?' regarding a treatment decision, the pharmacist BEST responds by:

Acknowledging the question, sharing relevant clinical information, then redirecting to what matters most to the patient (Correct answer)
Deferring entirely to the prescribing provider without further input
Refusing to answer to avoid influencing the patient's autonomy
Directly prescribing the pharmacist's personal preference

Correct answer: Acknowledging the question, sharing relevant clinical information, then redirecting to what matters most to the patient

Sharing evidence-based information while redirecting focus to the patient's own values and priorities honors both the patient's request for guidance and their autonomy.

Question 90: Which pharmacoeconomic analysis determines the cost per quality-adjusted life year (QALY) gained?

Cost-minimization analysis
Cost-utility analysis (Correct answer)
Cost-benefit analysis
Cost-effectiveness analysis

Correct answer: Cost-utility analysis

Cost-utility analysis incorporates patient preferences using QALYs to compare interventions.

Question 91: Which lipid parameter is most directly associated with atherogenesis and is the primary treatment target in cardiovascular risk reduction?

HDL-C
LDL-C (Correct answer)
VLDL-C
Triglycerides

Correct answer: LDL-C

LDL-C is the primary atherogenic lipoprotein and the principal target of lipid-lowering therapy to reduce cardiovascular risk.

Question 92: A pharmacist passed the BCACP exam in 2020. In what year must they recertify to maintain the credential?

2025
2030
2027 (Correct answer)
2028

Correct answer: 2027

The BCACP recertification cycle is 7 years, so a 2020 certification expires in 2027.

Question 93: For a patient with T2DM and established ASCVD, which medication class has the strongest evidence for reducing cardiovascular mortality as a first add-on to metformin?

DPP-4 inhibitors
GLP-1 receptor agonists or SGLT2 inhibitors (Correct answer)
Thiazolidinediones
Sulfonylureas

Correct answer: GLP-1 receptor agonists or SGLT2 inhibitors

ADA guidelines recommend GLP-1 receptor agonists or SGLT2 inhibitors with proven cardiovascular benefit as preferred add-ons to metformin in patients with established ASCVD.

Question 94: Which antihypertensive drug class is most associated with causing hyperkalemia in patients with CKD?

Alpha-1 blockers
ACE inhibitors (Correct answer)
Thiazide diuretics
Calcium channel blockers

Correct answer: ACE inhibitors

ACE inhibitors block angiotensin II–mediated aldosterone release, reducing potassium excretion and predisposing CKD patients to hyperkalemia.

Question 95: A pregnant patient in her first trimester is found to have a BP of 158/102 mmHg. Which antihypertensive is CONTRAINDICATED?

Nifedipine XL
Lisinopril (Correct answer)
Methyldopa
Labetalol

Correct answer: Lisinopril

ACE inhibitors are contraindicated in pregnancy due to risk of fetal renal dysgenesis, oligohydramnios, and neonatal renal failure.

Question 96: A 58-year-old patient with hypertension and CKD (eGFR 35 mL/min) needs antihypertensive therapy. Which agent provides both BP control and renoprotection?

Hydrochlorothiazide
Amlodipine
ACE inhibitor (Correct answer)
Metoprolol

Correct answer: ACE inhibitor

ACE inhibitors reduce intraglomerular pressure and proteinuria, providing renoprotection in CKD patients with hypertension.

Question 97: A patient on rosuvastatin 20 mg develops unexplained muscle pain. CK is 12,000 U/L. What is the most appropriate action?

Add CoQ10 and continue rosuvastatin
Reduce rosuvastatin to 10 mg
Switch to pravastatin 40 mg
Discontinue rosuvastatin immediately (Correct answer)

Correct answer: Discontinue rosuvastatin immediately

Markedly elevated CK (>10× ULN) with muscle symptoms indicates myopathy/rhabdomyolysis and requires immediate statin discontinuation.

Question 98: A patient on warfarin dramatically increases consumption of kale, spinach, and broccoli. What is the most likely effect on their INR?

INR will decrease due to increased vitamin K intake (Correct answer)
INR will remain unchanged because diet does not affect warfarin
INR will increase due to enhanced anticoagulation
INR will fluctuate unpredictably with no consistent direction

Correct answer: INR will decrease due to increased vitamin K intake

Increased vitamin K intake from leafy greens enhances hepatic synthesis of vitamin K-dependent clotting factors, antagonizing warfarin and decreasing the INR.

Question 99: Which lipid-lowering drug is most associated with flushing as a side effect and requires premedication with aspirin?

Fenofibrate
Niacin (nicotinic acid) (Correct answer)
Colesevelam
Ezetimibe

Correct answer: Niacin (nicotinic acid)

Niacin causes prostaglandin-mediated cutaneous flushing; taking 325 mg aspirin 30 minutes before the dose significantly reduces this effect.

Question 100: What is the mechanism by which ivabradine reduces symptoms in stable heart failure with reduced ejection fraction?

Selectively inhibits the If (funny) current in the SA node, reducing heart rate (Correct answer)
Blocks beta-1 receptors in the myocardium
Increases vagal tone through muscarinic receptor activation
Inhibits calcium channels in vascular smooth muscle

Correct answer: Selectively inhibits the If (funny) current in the SA node, reducing heart rate

Ivabradine selectively inhibits the If current in the sinoatrial node, slowing heart rate without affecting myocardial contractility or blood pressure.

Question 101: Which organization administers the BCACP credential for ambulatory care pharmacists?

Board of Pharmacy Specialties (BPS) (Correct answer)
American Pharmacists Association (APhA)
American Society of Health-System Pharmacists (ASHP)
Accreditation Council for Pharmacy Education (ACPE)

Correct answer: Board of Pharmacy Specialties (BPS)

The Board of Pharmacy Specialties (BPS) administers the BCACP exam and credential.

Question 102: Which opioid use disorder (OUD) medication is the ONLY one approved by the FDA that can be prescribed in an office-based setting without a special waiver historically required under the DATA 2000 Act?

Buprenorphine/naloxone
Extended-release naltrexone (Vivitrol) (Correct answer)
Tramadol
Methadone (for OUD)

Correct answer: Extended-release naltrexone (Vivitrol)

Extended-release naltrexone (injectable) has no special prescribing restrictions and can be prescribed by any licensed provider, unlike methadone for OUD (OTP only) or buprenorphine (which historically required a waiver).

Question 103: When using the HAS-BLED score in a patient with atrial fibrillation, what does a score of ≥3 indicate?

High risk of bleeding, warrants caution and closer monitoring (Correct answer)
DOAC is preferred over warfarin
Anticoagulation is absolutely contraindicated
High risk of stroke without anticoagulation

Correct answer: High risk of bleeding, warrants caution and closer monitoring

HAS-BLED ≥3 indicates high bleeding risk, prompting caution and more frequent monitoring, but is not a contraindication to anticoagulation.

Question 104: A pharmacist is educating a patient on self-monitoring of blood glucose (SMBG). Which instruction is MOST important for a patient starting insulin?

Record glucose readings with time, meals, and insulin doses to identify patterns and guide dose adjustments (Correct answer)
Only monitor fasting glucose; postprandial monitoring is not necessary
Check glucose only once weekly to avoid excessive testing
Monitor only when symptoms of hypoglycemia are present

Correct answer: Record glucose readings with time, meals, and insulin doses to identify patterns and guide dose adjustments

Structured SMBG with documentation of timing, meals, and doses enables meaningful pattern recognition essential for safe and effective insulin titration.

Question 105: Which DPP-4 inhibitor requires dose adjustment in renal impairment and has the most documented clinical experience?

Alogliptin
Linagliptin
Saxagliptin
Sitagliptin (Correct answer)

Correct answer: Sitagliptin

Sitagliptin was the first DPP-4 inhibitor approved and requires dose reduction in moderate to severe renal impairment; linagliptin is the only DPP-4i that does NOT require renal dose adjustment.

Question 106: Which immunization is specifically recommended for adults asplenic or with functional asplenia to prevent encapsulated organism infections?

Tdap and varicella vaccines
Annual influenza vaccine only
Hepatitis A and B series only
PCV15 or PCV20 followed by PPSV23, plus meningococcal vaccines (MenACWY and MenB) (Correct answer)

Correct answer: PCV15 or PCV20 followed by PPSV23, plus meningococcal vaccines (MenACWY and MenB)

Asplenic patients are at high risk for infections with encapsulated organisms and require pneumococcal, meningococcal (MenACWY and MenB), and Hib vaccines.

Question 107: A patient with gout and hypertension is on losartan. The physician wants to switch to a different ARB. Which property of losartan is beneficial to retain for this patient?

Losartan has uricosuric properties that lower serum uric acid (Correct answer)
Losartan has the longest half-life among ARBs
Losartan is the only ARB with renal protective effects
Losartan has the fewest drug interactions among ARBs

Correct answer: Losartan has uricosuric properties that lower serum uric acid

Losartan uniquely among ARBs has uricosuric activity by blocking URAT1 in the renal tubule, making it the preferred ARB for patients with comorbid gout.

Question 108: Which of the following best defines a surrogate endpoint?

An endpoint used only in pharmacokinetic studies
A biomarker used as a substitute for a clinically meaningful outcome (Correct answer)
A secondary endpoint pre-specified in the protocol
The primary outcome measured in a trial

Correct answer: A biomarker used as a substitute for a clinically meaningful outcome

Surrogate endpoints are biomarkers (e.g., HbA1c, LDL-C) assumed to correlate with clinical outcomes but may not capture true patient benefit.

Question 109: A 62-year-old patient with hypertension is currently taking hydrochlorothiazide 25 mg, lisinopril 40 mg, and amlodipine 10 mg daily. Her average home blood pressure readings are 145/95 mmHg. She has no other significant comorbidities. Which of the following represents the best therapeutic addition to manage her resistant hypertension?

Spironolactone (Correct answer)
Doxazosin
Hydralazine
Clonidine

Correct answer: Spironolactone

This patient has resistant hypertension, defined as uncontrolled blood pressure despite the use of three antihypertensive agents of different classes, including a diuretic. For resistant hypertension, a mineralocorticoid receptor antagonist (MRA) like spironolactone is the preferred fourth-line agent, as demonstrated in the PATHWAY-2 trial. Clonidine, doxazosin, and hydralazine are considered alternative add-on agents but are not the preferred next step over spironolactone.

Question 110: A funnel plot in a meta-analysis is asymmetrical. This finding most likely indicates:

Publication bias may be present (Correct answer)
The meta-analysis included too few studies
The pooled effect is not statistically significant
High heterogeneity among included studies

Correct answer: Publication bias may be present

Asymmetry in a funnel plot suggests smaller studies with negative results may not have been published, indicating publication bias.

Question 111: Which of the following best describes the mechanism of action of pioglitazone in T2DM?

Inhibits intestinal glucose absorption
Activates PPAR-gamma to improve insulin sensitivity in peripheral tissues (Correct answer)
Inhibits hepatic glucose production via AMPK activation
Stimulates pancreatic beta-cell insulin secretion

Correct answer: Activates PPAR-gamma to improve insulin sensitivity in peripheral tissues

Pioglitazone is a thiazolidinedione that activates peroxisome proliferator-activated receptor gamma (PPAR-γ), improving insulin sensitivity in muscle, fat, and liver.

Question 112: A patient with uncontrolled hypertension states, "I know I should take my blood pressure pills, but I hate the side effects and I don't feel any different when I take them." Which response from the pharmacist best demonstrates the spirit of motivational interviewing?

"It sounds like you're frustrated that the medications make you feel worse without any noticeable benefit." (Correct answer)
"If you don't take your medication, you're at a very high risk for a stroke or heart attack."
"Why aren't you taking them? Don't you understand how important this is?"
"Let's switch you to a different medication that has fewer side effects. That will solve the problem."

Correct answer: "It sounds like you're frustrated that the medications make you feel worse without any noticeable benefit."

This response uses reflective listening and expresses empathy, which are key principles of motivational interviewing. It validates the patient's feelings and opens a non-judgmental space to discuss their ambivalence, rather than using scare tactics, offering premature solutions, or asking confrontational questions.

Question 113: A study applies Bonferroni correction when analyzing multiple secondary endpoints. What is the purpose of this adjustment?

To control the family-wise Type I error rate when performing multiple comparisons (Correct answer)
To increase statistical power for each comparison
To adjust for confounding variables
To reduce Type II error across all endpoints

Correct answer: To control the family-wise Type I error rate when performing multiple comparisons

Bonferroni correction divides the alpha level by the number of comparisons to reduce the chance of false positive results.

Question 114: A patient with HFrEF, EF 30%, NYHA class II, already on optimal medical therapy including an ACE inhibitor, beta-blocker, and aldosterone antagonist, has an EKG showing LBBB with QRS duration of 158 ms. What additional therapy should be recommended?

Hydralazine/isosorbide dinitrate
Cardiac resynchronization therapy (CRT) (Correct answer)
Ranolazine
Digoxin

Correct answer: Cardiac resynchronization therapy (CRT)

CRT is indicated in HFrEF patients with EF ≤35%, NYHA class II-IV on optimal medical therapy with LBBB and QRS ≥150 ms, as it improves symptoms, EF, and reduces mortality.

Question 115: A patient with a penicillin allergy documented as 'rash' needs treatment for community-acquired pneumonia. What is the most appropriate approach?

Perform allergy risk stratification; a low-risk history may allow use of cephalosporins (Correct answer)
Avoid all beta-lactams and use a fluoroquinolone only
Administer amoxicillin with monitoring due to cross-reactivity being minimal
Refer to allergist before initiating any antibiotic

Correct answer: Perform allergy risk stratification; a low-risk history may allow use of cephalosporins

A non-severe penicillin allergy history (e.g., rash) warrants risk stratification; cross-reactivity with cephalosporins is low and cephalosporins can often be used safely.

Question 116: A pharmacist who recently obtained the BCACP credential is asked by a colleague what the letters after their name signify. Which of the following best describes the BCACP credential?

An ACPE accreditation for ambulatory care residency programs
A board certification recognizing advanced competence in ambulatory care pharmacy practice (Correct answer)
A state licensure designation for clinical pharmacists
A fellowship designation awarded by a professional pharmacy organization

Correct answer: A board certification recognizing advanced competence in ambulatory care pharmacy practice

BCACP is a BPS board certification that validates advanced clinical competence in ambulatory care pharmacy.

Question 117: A pharmacist applying for the BCACP exam for the first time must meet which minimum practice eligibility requirement?

5 years of any clinical pharmacy experience
Completion of a PGY-1 residency only
Board certification in pharmacotherapy (BCPS) is required first
Active licensure plus at least 50% of practice time in ambulatory care for the past 3 years or an APhA fellowship (Correct answer)

Correct answer: Active licensure plus at least 50% of practice time in ambulatory care for the past 3 years or an APhA fellowship

BPS requires current licensure and at least 50% of practice time in ambulatory care over the 3 years prior to application.

Question 118: Which vaccine requires a 2-dose series given 2–6 months apart and is preferred over the older zoster vaccine for shingles prevention in adults ≥50?

Proquad
Varivax
Zostavax (ZVL)
Shingrix (RZV) (Correct answer)

Correct answer: Shingrix (RZV)

Shingrix (recombinant zoster vaccine) is preferred over Zostavax with >90% efficacy and a 2-dose schedule recommended for adults ≥50.

Question 119: A pharmacist is applying for a federally qualified health center (FQHC) position that lists BCACP as required. Which of the following explains why FQHCs may specifically require this credential?

BCACP allows pharmacists to bill independently under FQHC cost-based reimbursement without physician supervision
FQHCs require BCACP solely because it reduces liability insurance costs
Federal law mandates BCACP for all pharmacists working in FQHCs
FQHCs serve complex, underserved populations and require pharmacists with demonstrated advanced ambulatory care competency (Correct answer)

Correct answer: FQHCs serve complex, underserved populations and require pharmacists with demonstrated advanced ambulatory care competency

FQHCs often require BCACP because they serve high-risk, underserved patients who benefit most from pharmacists with validated ambulatory care expertise.

Question 120: A pharmacist counsels a patient starting sacubitril/valsartan who was previously on an ACE inhibitor. What is the mandatory washout period between stopping the ACE inhibitor and starting sacubitril/valsartan?

48 hours
72 hours
36 hours (Correct answer)
24 hours

Correct answer: 36 hours

A minimum 36-hour washout after the last ACE inhibitor dose is required before starting sacubitril/valsartan to prevent life-threatening angioedema from neprilysin-ACE inhibitor-mediated bradykinin accumulation.

Question 121: When counseling a patient starting isoniazid (INH) for latent TB, which supplement should be co-prescribed to prevent peripheral neuropathy?

Thiamine (vitamin B1) 100 mg daily
Folate 1 mg daily
Cyanocobalamin (vitamin B12) 1000 mcg daily
Pyridoxine (vitamin B6) 25–50 mg daily (Correct answer)

Correct answer: Pyridoxine (vitamin B6) 25–50 mg daily

Isoniazid inhibits pyridoxine metabolism, increasing neuropathy risk; pyridoxine supplementation is recommended especially in at-risk patients.

Question 122: A diabetic patient develops a foot infection with purulent drainage. Which organism is most commonly responsible for mild-to-moderate diabetic foot infections?

Pseudomonas aeruginosa
Escherichia coli
Staphylococcus aureus (Correct answer)
Clostridium perfringens

Correct answer: Staphylococcus aureus

Staphylococcus aureus, including MRSA, is the predominant pathogen in mild-to-moderate diabetic foot infections.

Question 123: A pharmacist is counseling a patient starting insulin glargine. Which statement about insulin glargine storage is correct?

Opened vials must be discarded after 14 days
Unopened pens can be stored at room temperature indefinitely
Insulin glargine must always be refrigerated, even after opening
Once opened, insulin glargine can be kept at room temperature for up to 28 days (Correct answer)

Correct answer: Once opened, insulin glargine can be kept at room temperature for up to 28 days

Once opened (in-use), insulin glargine vials and pens can be stored at room temperature (below 86°F/30°C) for up to 28 days.

Question 124: A 72-year-old woman with hypertension, osteoporosis, and no prior CV events has a 10-year ASCVD risk of 9%. The clinician and patient are uncertain about statin therapy. What is the most appropriate next step?

Start aspirin therapy instead of statin
Start high-intensity statin immediately
Use risk-enhancing factors to guide the statin discussion (Correct answer)
Defer all treatment for 2 years

Correct answer: Use risk-enhancing factors to guide the statin discussion

For borderline-risk patients (7.5–20%), ACC/AHA guidelines recommend using risk-enhancing factors to refine the statin initiation decision.

Question 125: Which of the following BEST describes the role of a BCACP pharmacist in a patient-centered medical home (PCMH)?

Reviewing charts without direct patient interaction
Acting as the primary decision-maker for all drug therapy
Dispensing medications and processing refills
Serving as an integrated care team member providing medication management and chronic disease optimization (Correct answer)

Correct answer: Serving as an integrated care team member providing medication management and chronic disease optimization

In a PCMH, the ambulatory care pharmacist functions as an integrated team member who collaborates with providers and patients to optimize medication therapy and chronic disease outcomes.

Question 126: A pharmacist reviews a patient's chart and notes that 3 days post-STEMI, the patient's troponin is still elevated. The prescriber asks about starting a statin. What is the correct recommendation?

Start only if LDL-C is above 190 mg/dL
Start high-intensity statin immediately regardless of baseline LDL-C (Correct answer)
Defer statin until troponin normalizes
Statin therapy is not indicated for troponin-positive events

Correct answer: Start high-intensity statin immediately regardless of baseline LDL-C

High-intensity statin therapy should be initiated as early as possible after ACS regardless of baseline LDL-C levels, as statins provide pleiotropic benefits beyond LDL lowering in this acute setting.

Question 127: Which element of the chronic care model supports patient self-management education as a core component?

Self-management support empowering patients with skills and confidence to manage their health (Correct answer)
Clinical information systems for provider alerts only
Community resource utilization restricted to social workers
Health system support via specialist referrals only

Correct answer: Self-management support empowering patients with skills and confidence to manage their health

The Chronic Care Model identifies self-management support — equipping patients with problem-solving skills and confidence — as a foundational element for improving chronic disease outcomes.

Question 128: A patient on phenytoin for seizure disorder is started on oral contraceptives. What counseling point is most critical?

Phenytoin increases OCP effectiveness
OCPs increase phenytoin levels, raising toxicity risk
Phenytoin induces CYP enzymes, reducing OCP plasma levels and efficacy (Correct answer)
No interaction exists between phenytoin and OCPs

Correct answer: Phenytoin induces CYP enzymes, reducing OCP plasma levels and efficacy

Phenytoin is a potent CYP3A4 inducer that accelerates metabolism of ethinyl estradiol and progestin, potentially leading to contraceptive failure.

Question 129: A clinical trial evaluates a new medication for stroke prevention in patients with atrial fibrillation. The results for the primary outcome of ischemic stroke are reported as a Hazard Ratio (HR) of 0.80 with a 95% Confidence Interval (CI) of 0.65 to 1.05. Which of the following is the most accurate interpretation of this finding?

The p-value must be less than 0.05.
The new medication is inferior to the comparator for stroke prevention.
The result is not statistically significant. (Correct answer)
The new medication is superior to the comparator for stroke prevention.

Correct answer: The result is not statistically significant.

For a ratio metric like a Hazard Ratio (HR), Relative Risk (RR), or Odds Ratio (OR), the null value (representing no difference between groups) is 1.0. A 95% Confidence Interval indicates a range where the true effect is likely to lie. Because this 95% CI (0.65 to 1.05) crosses 1.0, we cannot exclude the possibility of no difference. Therefore, the result is not statistically significant at the p<0.05 level.

Question 130: Which measure is most appropriate for evaluating the effectiveness of a population-based diabetes management program at a health system level?

HbA1c <8% in individual patients
Fasting glucose values at last visit
Number of endocrinology referrals made
Percentage of diabetic patients with HbA1c <8% across the panel (Correct answer)

Correct answer: Percentage of diabetic patients with HbA1c <8% across the panel

Population-based care focuses on panel-level metrics (e.g., proportion meeting HbA1c goals) rather than individual patient outcomes.

Question 131: A patient with schizophrenia is inconsistently adherent to their antipsychotic medication. The MOST patient-centered intervention would be to:

Explore the patient's barriers to adherence and collaboratively develop solutions (Correct answer)
Provide written reminders and discharge the patient from care
Switch to a longer-acting injectable formulation without discussion
Notify the prescriber to add a second antipsychotic

Correct answer: Explore the patient's barriers to adherence and collaboratively develop solutions

Collaboratively identifying adherence barriers respects the patient's perspective and increases the likelihood of finding a sustainable solution.

Question 132: A clinic implements a team-based care model where the pharmacist manages the diabetes population independently within a collaborative practice agreement. The primary advantage of this model for population health is:

It allows efficient, protocol-driven optimization of therapy for a large patient panel (Correct answer)
Physicians are no longer responsible for diabetes management
Patients can bypass primary care visits entirely
Pharmacists can bill independently without physician oversight

Correct answer: It allows efficient, protocol-driven optimization of therapy for a large patient panel

Collaborative practice agreements allow pharmacists to manage panels efficiently using evidence-based protocols, expanding care capacity without compromising safety.

Question 133: Which statistical test is most appropriate for comparing means across three or more independent groups in a clinical trial?

Chi-square test
Paired t-test
One-way ANOVA (Correct answer)
Pearson correlation

Correct answer: One-way ANOVA

One-way ANOVA compares means among three or more independent groups simultaneously.

Question 134: A 48-year-old male with no history of ASCVD has a 10-year ASCVD risk of 15% calculated using the PREVENT equations. His LDL-C is 145 mg/dL despite lifestyle modifications. According to the 2026 ACC/AHA Dyslipidemia Guideline, which of the following is the most appropriate initial therapy?

Ezetimibe 10 mg daily
Atorvastatin 40 mg daily (Correct answer)
Pravastatin 20 mg daily
Lovastatin 10 mg daily

Correct answer: Atorvastatin 40 mg daily

For primary prevention in a patient with an intermediate to high 10-year ASCVD risk (≥7.5% to <20%), guidelines recommend initiating a moderate-intensity statin. However, given the risk of 15% and an LDL-C well above the goal of <100 mg/dL, initiating a high-intensity statin like atorvastatin 40 mg to achieve at least a 50% reduction in LDL-C is a reasonable and often preferred approach. Atorvastatin 40 mg is a high-intensity statin, while pravastatin 20 mg and lovastatin 10 mg are low-intensity. Ezetimibe is not a first-line agent for primary prevention.

Question 135: A patient with hypertension and a history of angioedema on enalapril is started on sacubitril/valsartan for HFrEF. What important counseling point applies?

There must be a 36-hour washout period after stopping the ACE inhibitor before starting sacubitril/valsartan
The patient should take a 24-hour break before transitioning
Sacubitril/valsartan is safe because it is not an ACE inhibitor
Sacubitril/valsartan is contraindicated in patients with prior ACE inhibitor angioedema (Correct answer)

Correct answer: Sacubitril/valsartan is contraindicated in patients with prior ACE inhibitor angioedema

A history of ACE inhibitor–induced angioedema is a contraindication to sacubitril/valsartan because neprilysin inhibition further raises bradykinin levels, increasing angioedema risk.

Question 136: A randomized controlled trial reports a relative risk reduction (RRR) of 30% for a primary endpoint. The control event rate is 5%. What is the absolute risk reduction (ARR)?

1.5% (Correct answer)
5%
30%
25%

Correct answer: 1.5%

ARR = RRR × control event rate = 0.30 × 5% = 1.5%.

Question 137: Which first-line antidepressant class is preferred for treating major depressive disorder in ambulatory care due to its favorable safety profile?

Monoamine oxidase inhibitors (MAOIs)
Tricyclic antidepressants (TCAs)
Benzodiazepines
Selective serotonin reuptake inhibitors (SSRIs) (Correct answer)

Correct answer: Selective serotonin reuptake inhibitors (SSRIs)

SSRIs are first-line for MDD due to their tolerability and safety compared to older antidepressant classes.

Question 138: Which atypical antipsychotic requires mandatory enrollment in a REMS program due to risk of agranulocytosis?

Risperidone
Clozapine (Correct answer)
Quetiapine
Aripiprazole

Correct answer: Clozapine

Clozapine has a REMS program (CLOZAPINE REMS) requiring ANC monitoring due to its risk of life-threatening agranulocytosis.

Question 139: A pharmacist is counseling a patient on naloxone use. The patient's caregiver asks when to administer naloxone. Which clinical sign is the MOST important indicator of opioid overdose requiring immediate naloxone administration?

Nausea and vomiting after taking opioids
Slow, shallow respirations (fewer than 12 breaths per minute) with unresponsiveness (Correct answer)
Excessive sedation and miosis (pinpoint pupils)
Constipation and urinary retention

Correct answer: Slow, shallow respirations (fewer than 12 breaths per minute) with unresponsiveness

The hallmark indication for naloxone administration is respiratory depression — specifically slow, shallow breathing (fewer than 12 breaths/min) combined with unresponsiveness or unconsciousness. This represents life-threatening opioid toxicity. Sedation and miosis are expected opioid effects and do not alone require naloxone. Nausea and constipation are common opioid side effects, not overdose signs. The opioid overdose triad is: pinpoint pupils + respiratory depression + unconsciousness.

Question 140: A 70-year-old patient is on simvastatin 40 mg and is newly started on amlodipine. What drug interaction concern exists?

Amlodipine displaces simvastatin from plasma proteins
No clinically significant interaction exists
Amlodipine inhibits CYP3A4 and increases simvastatin exposure (Correct answer)
Amlodipine reduces simvastatin efficacy

Correct answer: Amlodipine inhibits CYP3A4 and increases simvastatin exposure

Amlodipine weakly inhibits CYP3A4 and can modestly increase simvastatin plasma levels, potentially increasing myopathy risk.

Question 141: Which combination of antihypertensive agents is generally avoided due to the highest risk of acute kidney injury and hyperkalemia?

ACE inhibitor plus calcium channel blocker
Beta-blocker plus calcium channel blocker
ACE inhibitor plus ARB (Correct answer)
ARB plus thiazide diuretic

Correct answer: ACE inhibitor plus ARB

Dual RAAS blockade with an ACE inhibitor plus ARB significantly increases the risk of hypotension, hyperkalemia, and acute kidney injury without added cardiovascular benefit over monotherapy.

Question 142: A BCACP pharmacist notices that a colleague is incorrectly using 'BCACP' in their email signature despite having only passed Part 1 of the application process. What is the most professionally appropriate response?

Privately inform the colleague that the credential should only be listed after official BPS award confirmation (Correct answer)
Report the colleague immediately to the state board of pharmacy
Ignore the situation, as credential use is a personal choice
Post a correction on the department bulletin board to inform other staff

Correct answer: Privately inform the colleague that the credential should only be listed after official BPS award confirmation

A private, collegial conversation is the most professional first step to correct misuse of a credential before escalating.

Question 143: What is the recommended post-exposure prophylaxis (PEP) window for HIV initiation after a high-risk exposure?

Within 72 hours (Correct answer)
Within 2 weeks
Within 24 hours only
Within 1 week

Correct answer: Within 72 hours

HIV PEP must be initiated within 72 hours of exposure and continued for 28 days to be effective.

Question 144: A 70-year-old patient with chronic stable angina is optimally treated with metoprolol succinate and amlodipine but remains symptomatic. What is the most appropriate add-on antianginal therapy?

Ranolazine
Either ranolazine or a long-acting nitrate are appropriate add-on options (Correct answer)
Ivabradine (if HR >70 bpm and sinus rhythm)
Long-acting nitrate

Correct answer: Either ranolazine or a long-acting nitrate are appropriate add-on options

Both ranolazine and long-acting nitrates are appropriate add-on antianginal agents when patients remain symptomatic on beta-blocker plus calcium channel blocker therapy.

Question 145: A 58-year-old post-MI patient on aspirin 81 mg and clopidogrel asks about taking ibuprofen for arthritis pain. What is the pharmacist's primary concern?

Ibuprofen increases the risk of bleeding when combined with clopidogrel only
Ibuprofen competitively inhibits the COX-1 binding site, blocking aspirin's irreversible antiplatelet effect (Correct answer)
Ibuprofen reduces clopidogrel absorption from the GI tract
No interaction exists; only GI bleeding risk from combined use

Correct answer: Ibuprofen competitively inhibits the COX-1 binding site, blocking aspirin's irreversible antiplatelet effect

Ibuprofen (and other NSAIDs) reversibly occupy the COX-1 active site, sterically blocking aspirin's irreversible acetylation, thereby attenuating aspirin's antiplatelet efficacy if taken before aspirin.

Question 146: A patient is on amlodipine 10 mg and lisinopril 20 mg but BP remains 150/92 mmHg. Which add-on therapy is most guideline-supported for a third-line agent?

Clonidine
Hydralazine
Chlorthalidone (Correct answer)
Doxazosin

Correct answer: Chlorthalidone

JNC and ACC/AHA guidelines recommend a thiazide-type diuretic (preferably chlorthalidone) as the third drug in a three-drug combination regimen for resistant hypertension.

Question 147: A pharmacy director is negotiating a value-based contract with a payer. Which metric would BEST demonstrate the pharmacy team's impact on total cost of care?

Medication adherence rates for chronic disease medications (Correct answer)
Number of prescription refills processed per month
Average copay collected per patient visit
Pharmacy technician certification rate

Correct answer: Medication adherence rates for chronic disease medications

Medication adherence is directly linked to reduced hospitalizations, ER visits, and downstream costs, making it a powerful value-based metric.

Question 148: A clinical trial for a new heart failure medication reports a statistically significant reduction in its primary composite endpoint of 'cardiovascular death, hospitalization for heart failure, or urgent heart failure visit.' An analysis of the individual components reveals the benefit was driven almost exclusively by a reduction in urgent heart failure visits, with no significant difference in CV death or hospitalizations. What is the most appropriate clinical interpretation?

The drug is likely to show a mortality benefit if the trial is extended for a longer duration.
The composite endpoint is invalid and the study results should be disregarded entirely.
The drug is proven effective at reducing mortality and hospitalizations in patients with heart failure.
The benefit of the drug is primarily related to reducing less severe events like urgent heart failure visits. (Correct answer)

Correct answer: The benefit of the drug is primarily related to reducing less severe events like urgent heart failure visits.

When evaluating a composite endpoint, it is crucial to examine the individual components to understand the true effect of the intervention. A significant result for the composite does not automatically apply to all its components. In this case, the benefit was driven by the softest, least severe endpoint, so the most accurate interpretation is that the drug's main effect is on reducing urgent HF visits, not necessarily on the more severe outcomes of hospitalization or death.

Question 149: Health literacy is BEST defined as:

The level of formal education a patient has completed
A patient's agreement with provider recommendations
A patient's ability to read medical textbooks
The capacity to obtain, process, and understand health information needed to make decisions (Correct answer)

Correct answer: The capacity to obtain, process, and understand health information needed to make decisions

Health literacy encompasses not only reading ability but also the cognitive and social skills needed to access and apply health information.

Question 150: Which GLP-1 receptor agonist is FDA-approved for once-weekly subcutaneous injection and has demonstrated cardiovascular outcome benefits in the LEADER trial?

Dulaglutide
Semaglutide
Exenatide extended-release
Liraglutide (Correct answer)

Correct answer: Liraglutide

Liraglutide (Victoza) was studied in the LEADER trial, demonstrating significant reduction in major adverse cardiovascular events in high-risk T2DM patients.

Board Certified Ambulatory Care Pharmacist (BCACP) Exam

The BCACP certification, administered by the Board of Pharmacy Specialties (BPS), validates a pharmacist's advanced competency in ambulatory care practice including patient-centered medication therapy management, clinical literature interpretation, and population-based care.

150

Questions

225 min

Time Limit

62%

To Pass

Checking for saved progress...

Exam Rules

You can skip questions and return to them later
Flag questions for review before submitting
No feedback shown until you submit the entire exam
Unanswered questions count as wrong — answer everything
10 pretest questions are mixed in and don't affect your score
Timer auto-submits when time runs out
Your progress is auto-saved every 30 seconds